<?xml-stylesheet type="text/xsl" href="ViewNLM-v2.3.xsl"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id><journal-id journal-id-type="publisher-id">JKMS</journal-id><journal-title-group><journal-title>Journal of Korean Medical Science</journal-title></journal-title-group><issn pub-type="ppub">1011-8934</issn><issn pub-type="epub">1598-6357</issn><publisher><publisher-name>The Korean Academy of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.3346/jkms.2006.21.2.208</article-id><article-id pub-id-type="pmid">16614502</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Insertion/Deletion Polymorphism of Angiotensin Converting Enzyme Gene in Kawasaki Disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shim</surname><given-names>Yoon Hee</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Kim</surname><given-names>Hae Soon</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Sohn</surname><given-names>Sejung</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Hong</surname><given-names>Young Mi</given-names></name><xref ref-type="aff" rid="A1"/></contrib></contrib-group><aff id="A1">Department of Pediatrics, College of Medicine, Ewha Womans University, Seoul, Korea.</aff><author-notes><corresp> Address for correspondence: Hae Soon Kim, M.D. Department of Pediatrics, Ewha Womans University Mokdong Hospital, 911-1 Mok-dong, Yangcheon-gu, Seoul 158-710, Korea. Tel: +82.2-2650-5569, Fax: +82.2-2653-3718, <email>hyesk@ewha.ac.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>4</month><year>2006</year></pub-date><pub-date pub-type="epub"><day>20</day><month>4</month><year>2006</year></pub-date><volume>21</volume><issue>2</issue><fpage>208</fpage><lpage>211</lpage><history><date date-type="received"><day>08</day><month>6</month><year>2005</year></date><date date-type="accepted"><day>29</day><month>9</month><year>2005</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2006 The Korean Academy of Medical Sciences</copyright-statement><copyright-year>2006</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Polymorphism of angiotensin converting enzyme (<italic>ACE</italic>) gene is reported to be associated with ischemic heart disease, hypertrophic cardiomyopathy, and idiopathic dilated cardiomyopathy. In this study, we investigated the relationship between Kawasaki disease and insertion/deletion polymorphism of <italic>ACE</italic> gene. Fifty five Kawasaki disease patients and 43 healthy children were enrolled. <italic>ACE</italic> genotype was evaluated from each of the subjects' DNA fragments through polymerase chain reaction (PCR). Frequencies of <italic>ACE</italic> genotypes (DD, ID, II) were 12.7%, 60.0%, 27.3% in Kawasaki group, and 41.9%, 30.2%, 27.9% in control group respectively, indicating low rate of DD and high rate of ID genotype among Kawasaki patients (<italic>p</italic>&#x0003c;0.01). Comparing allelic (I, D) frequencies, I allele was more prevalent in Kawasaki group than in control group (57.3% vs. 43.0%, <italic>p</italic>&#x0003c;0.05). In Kawasaki group, both genotype and allelic frequencies were not statistically different between those with coronary dilatations and those without. <italic>ACE</italic> gene I/D polymorphism is thought to be associated with Kawasaki disease but not with the development of coronary dilatations.</p></abstract><kwd-group><kwd>Mucocutaneous Lymph Node Syndrome</kwd><kwd>Kawasaki Disease</kwd><kwd>Peptidyl-Dipeptidase A</kwd><kwd>Angiotensin Converting Enzyme</kwd><kwd>Polymorphism, Genetic</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Kawasaki disease is an acute systemic vasculitis and its diagnosis is made on clinical features. Main complication of the disease is coronary artery lesion that may result in myocardial infarction or sudden death. Coronary artery aneurysms or ectasia develop in approximately 15-25% of untreated children (<xref ref-type="bibr" rid="B1">1</xref>). Since the intravenous immune globulin (IVIG) and aspirin therapy have been introduced, its mortality rate has decreased to 0.1%, but cardiac sequelae continues to occur in about 13% of Kawasaki disease patients (<xref ref-type="bibr" rid="B2">2</xref>).</p><p>The etiology of Kawasaki disease is largely unknown despite the various suggested hypotheses. Based on epidemiologic and clinical manifestations, it is thought that Kawasaki disease is caused by some infectious agents (<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B10">10</xref>). Hypercytokinemia and hyperchemokinemia have also been observed and are thought to cause vascular injuries by inflammatory reaction and immunologic activation (<xref ref-type="bibr" rid="B11">11</xref>). Genetic factors are also thought to have influences on the development and progress of Kawasaki disease (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Up to present days, Kawasaki disease is thought to be an infectious disease manifested by immunologic reaction in genetically susceptable person.</p><p>Angiotensin converting enzyme (ACE) breaks down the potent vasodilator, bradykinin to its inactivate metabolite and catalyzes angiotensin I to angiotensin II. Angiotensin II promotes hyperplasia and hypertrophy of vascular smooth muscle cells, induces the production of proinflammatory cytokines and causes endothelial dysfunction by free radical generation. By playing an important role in cardiovascular regulatory system, <italic>ACE</italic> gene has been proposed to be associated with various cardiovascular diseases, such as ischemic heart disease, hypertrophic cardiomyopathy, idiopathic dilated cardiomyopathy, and vascular hypertrophy (<xref ref-type="bibr" rid="B14">14</xref>). Among the different <italic>ACE</italic> genetic loci, the insertion/deletion polymorphism coded within intron 16 has been studied in many literature to find the association with such diseases.</p><p>However, there has been few studies regarding the association between the polymorphism of <italic>ACE</italic> gene and Kawasaki disease. The present study investigates whether the I/D polymorphism of <italic>ACE</italic> gene (DD, ID, II) is associated with the prevalence and severity of Kawasaki disease among Korean pediatric populations.</p></sec><sec sec-type="methods"><title>MATERIALS AND METHODS</title><sec><title>Study subjects</title><p>Fifty five Kawasaki patients (mean age 28.2&#x000b1;25.2 months) diagnosed at Ewha Womans University Mokdong Hospital from January 2001 to June 2003, and 43 healthy children (mean age 28.5&#x000b1;17.2 months) were enrolled. Kawasaki disease was diagnosed by its clinical features, that is fever lasting for at least 5 days, accompanied by 4 of the 5 classical signs: 1) bilateral bulbar conjunctival injection; 2) pharynx, injected and/or dry fissured lips, strawberry tongue; 3) changes of the peripheral extremities in the acute phase or periungal desquamation in the subacute phase; 4) nonvesicular rash; 5) cervical adenopathy, &#x02265;1.5 cm. The diagnosis was made if he/she had typical manifestations even before less than 5 febrile days of illness. All patients were treated with immunoglobulin (2 g/kg) on the day of diagnosis. High dose (50 mg/kg/day) aspirin was given from the day of diagnosis and its dosage was changed to 5 mg/kg/day after 2 nonfebrile consecutive days.</p><p>Two dimensional echocardiography was done to evaluate cardiac complications. Coronary arterial lesion was defined as following: 1) inner diameter that is &#x0003e;3 mm in children &#x0003c;5 yrs old and &#x0003e;4 mm in children &#x02265;5 yrs old; 2) internal diameter of a segment &#x02265;1.5 times that of an adjacent segment; or 3) lumen with irregular surface. Among these patients, 17 showed coronary dilatations and 38 did not.</p><p>Informed consent was obtained from his/her parents prior to the participation in the study. The study was approved by the hospital's ethics commitee.</p></sec><sec><title>ACE genotyping</title><p>Each of the subjects' DNA was extracted from whole blood at the time of diagnosis using QIAamp DNA Blood Mini Kit (Gene Company LTD., Chai Wan, Hong Kong). DNA fragments were amplified through polymerase chain reaction (PCR), which was carried out in a total volume of 10 &#x000b5;L containing 50 ng of genomic DNA, 200 mM dNTPs, 0.3 mM/mL of each primers (5'-CTGGAGACCACTCCCATCCTTTCT); (5'-GATGTGGCCATCACATTCGTCAGAT) in PCR buffer with 0.5 units <italic>Taq</italic> DNA polymerase (Takara, Shiga, Japan). After the initial denaturation step (10 min at 95&#x02103;), 35 cycles were repeated for 30 sec at 94&#x02103;, 30 sec at 52&#x02103;, 90 sec at 72&#x02103;, and 5 min at 72&#x02103;. DNA fragments were then separated by electrophoresis on 2.5% agarose gel.</p></sec><sec><title>Statistical analysis</title><p>Student's t-test was used to compare the demographic characteristics between the two groups. Chi square test and Fisher exact test were performed to compare the genotype and allelic frequencies between the two groups. Its frequencies were compared by odds ratio. <italic>p</italic> value less than 0.05 was considered significant.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>The mean age of Kawasaki group (28 boys and 27 girls) was 28.2&#x000b1;25.2 months, and that of the control group (30 boys and 13 girls) was 28.5&#x000b1;17.2 months. Among 55 Kawasaki disease patients, coronary dilatation was observed in 17 patients (8 boys and 9 girls, <xref ref-type="table" rid="T1">Table 1</xref>)</p><p>Frequencies of <italic>ACE</italic> genotypes (DD, ID, II) were 12.7%, 60.0%, 27.3% in Kawasaki group, and 41.9%, 30.2%, 27.9% in control group respectively, indicating low rate of DD genotype (<italic>p</italic>&#x0003c;0.01, odds ratio=0.2) and high rate of ID genotype (<italic>p</italic>&#x0003c;0.01, odds ratio=3.3) among Kawasaki patients (<xref ref-type="table" rid="T2">Table 2</xref>).</p><p>Comparing allelic (I, D) frequencies, I allele was more prevalent in Kawasaki group than in control group (57.3% vs. 43.0%, <italic>p</italic>&#x0003c;0.05, odds ratio=1.78, <xref ref-type="table" rid="T3">Table 3</xref>).</p><p>In Kawasaki group, both genotype (DD, ID, II) and allelic frequencies were not statistically different between those with coronary dilatations and those without (<xref ref-type="table" rid="T4">Table 4</xref>, <xref ref-type="table" rid="T5">5</xref>).</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The <italic>ACE</italic> gene is localized on chromosome 17q23 and is characterized by a major insertion/deletion polymorphism consisting of the presence or absence of a 287-base pair <italic>Alu</italic> repeat sequence within intron 16 (<xref ref-type="bibr" rid="B15">15</xref>). Angiotensin converting enzyme is an ectoenzyme found on the external surface of the endothelial and epithelial cell membranes. It enhances the synthesis of angiotensin-II, that promotes proliferation, migration, and hypertrophy of vascular smooth muscle cells. Angiotensin II also induces the production of proinflammatory cytokines and matrix metalloproteinases (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). Moreover, the increased free radical generation by angiotensin-II contributes to endothelial dysfunction (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>).</p><p>In humans, the ACE activity is partly under genetic control. It is suggested that about half of the interindividual difference in ACE levels may be accounted for its polymorphism (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). It is reported that mean <italic>ACE</italic> levels were lowest for II homozygotes, highest for DD homozygotes, and intermediate for ID heterozygotes (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B21">21</xref>). Danser et al. explained the higher ACE levels observed in subjects with D allele than those with the II genotype by the sequence harbored in the insert of <italic>ACE</italic> gene. This sequence was said to be very similar to a silencer element (<xref ref-type="bibr" rid="B22">22</xref>). But it is not clear whether increased levels of ACE actually affects the levels of angiotenisn II because the renin-angiotensin system is regulated by feedback mechanism (<xref ref-type="bibr" rid="B22">22</xref>).</p><p>Angiotensin converting enzyme is mainly produced by vascular endothelial cells (<xref ref-type="bibr" rid="B23">23</xref>). In Kawasaki disease, the associated endothelial cell damage subsequently lowers the ACE level. It is reported in some literature (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>) that serum ACE levels are significantly attenuated during the acute phase, and recovered during the convalescent phase of Kawasaki disease.</p><p>Slowik et al. (<xref ref-type="bibr" rid="B26">26</xref>) reported that the II genotype of <italic>ACE</italic> gene contributes to vascular dilatation at the site of aneurysm by 1) increased bradykinin activity, 2) another polymorphism responsible for vascular dilatation that is in linkage disequilibrium with ACE I/D polymorphism, 3) degeneration of endothelial cells, or 4) lack of vascular remodeling.</p><p>There is pathological difference between adult coronary artery disease (CAD) and that caused by Kawasaki disease. CAD caused by Kawasaki disease is characterized by vascular intimal thickening, whereas the adult CAD is characterized by atherosclerotic lesions initiated by atheroma and plaque formation. Thus, the pathophysiologic mechanism of myocardial ischemic development is also different; in adult CAD, plaque rupture and thrombus formation plays the important role, whereas in Kawasaki disease, coronary arterial narrowing by intimal hyperplasia is responsible (<xref ref-type="bibr" rid="B24">24</xref>).</p><p>In this study, the ID genotype was more prevalent (59.3 vs. 30.2%, <italic>p</italic>&#x0003c;0.01), and the DD genotype (12.9 vs. 41.9%, <italic>p</italic>&#x0003c;0.01) was less prevalent in Kawasaki group than in control group. And I allele was more prevalent in Kawasaki group than in control group. However, both genotype (DD, ID, II) and allelic frequencies were not statistically different between Kawasaki disease patients with coronary dilatations and those without. Therefore, <italic>ACE</italic> gene I/D polymorphism was thought to be associated with the prevalence of Kawasaki disease but not with the development of coronary lesions. These results are similar to the report by Wu et al. (<xref ref-type="bibr" rid="B13">13</xref>) that the DD genotype was present in lower frequency among Kawasaki patients and <italic>ACE</italic> polymorphism was not associated with coronary aneurysmal formation. These results are different from the study by Takeuchi et al. (<xref ref-type="bibr" rid="B27">27</xref>) that the II genotype of <italic>ACE</italic> gene is more prevalent in Kawasaki disease and those with coronary aneurysm. These inconsistent results may be accounted for different ethnic traits of the individual population.</p><p>In conclusion, the ID genotype is present in a significantly higher frequency and DD in lower frequency among Kawasaki disease patients than in control subjects. In addition, there are no significant association between <italic>ACE</italic> I/D polymorphism and the coronary artery aneurysm formation in Kawasaki disease patients. Because the study groups are relatively small size in number, it is difficult to generalize these results. In this study, the coronary arterial dilatation was observed in 17 out of 55 Kawasaki patients. This is higher than that in previously reported literature. It can be accounted for either 1) longer duration from the onset of illness to the infusion of immunoglobulin, 2) other factors that may affect the development of coronary arterial lesions in Kawasaki disease, such as different ethinicity or 3) selection bias caused by limited number of enrolled institution and small number of patients. IVIG is recommended to be given within the first 10 days of illness and, if possible, within 7 days of illness. Since the duration of febrile days before the diagnosis and the IVIG infusion were 4.6&#x000b1;1.6 days (range, 2-8 days) in our study groups, the first explanation seems less likely.</p><p>Further study is required to clarity the association.</p></sec></body><back><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newburger</surname><given-names>JW</given-names></name><name><surname>Fulton</surname><given-names>DR</given-names></name></person-group><article-title>Kawasaki disease</article-title><source>Curr Opin Pediatr</source><year>2004</year><volume>16</volume><fpage>508</fpage><lpage>514</lpage><pub-id pub-id-type="pmid">15367843</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanagawa</surname><given-names>H</given-names></name><name><surname>Yashiro</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name></person-group><article-title>14th nationwide survey on Kawasaki disease</article-title><source>J Pediatr Practice</source><year>1998</year><volume>61</volume><fpage>406</fpage><lpage>420</lpage></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shulman</surname><given-names>ST</given-names></name><name><surname>Rowley</surname><given-names>AH</given-names></name></person-group><article-title>Does Kawasaki disease have a retroviral aetiology?</article-title><source>Lancet</source><year>1986</year><volume>2</volume><fpage>545</fpage><lpage>546</lpage><pub-id pub-id-type="pmid">2427900</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esper</surname><given-names>F</given-names></name><name><surname>Shapiro</surname><given-names>ED</given-names></name><name><surname>Weibel</surname><given-names>C</given-names></name><name><surname>Ferguson</surname><given-names>D</given-names></name><name><surname>Landry</surname><given-names>ML</given-names></name><name><surname>Kahn</surname><given-names>JS</given-names></name></person-group><article-title>Association between a novel human Coronavirus and Kawasaki disease</article-title><source>J Infect Dis</source><year>2005</year><volume>191</volume><fpage>499</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">15655771</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>CT</given-names></name><name><surname>Chang</surname><given-names>JS</given-names></name><name><surname>Ooi</surname><given-names>SE</given-names></name><name><surname>Huo</surname><given-names>AP</given-names></name><name><surname>Chang</surname><given-names>SJ</given-names></name><name><surname>Chang</surname><given-names>HN</given-names></name><name><surname>Tsai</surname><given-names>CY</given-names></name></person-group><article-title>Serum anti-Yersinia antibody in Chinese patients with Kawasaki disease</article-title><source>Arch Med Res</source><year>2005</year><volume>36</volume><fpage>14</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">15777989</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagiwara</surname><given-names>K</given-names></name><name><surname>Komura</surname><given-names>H</given-names></name><name><surname>Kishi</surname><given-names>P</given-names></name><name><surname>Kaji</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name></person-group><article-title>Isolation of human herpesvirus-6 from an infant with Kawasaki disease</article-title><source>Eur J Pediatr</source><year>1992</year><volume>151</volume><fpage>867</fpage><lpage>868</lpage><pub-id pub-id-type="pmid">1334835</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baba</surname><given-names>K</given-names></name><name><surname>Takeda</surname><given-names>N</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name></person-group><article-title>Cases of Yersinia pseudotuberculosis infection having diagnostic criteria of Kawasaki disease</article-title><source>Contrib Microbiol Immunol</source><year>1991</year><volume>12</volume><fpage>292</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">1935106</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DH</given-names></name><name><surname>Huang</surname><given-names>HP</given-names></name></person-group><article-title>Kawasaki disease associated with chickenpox: report of two sibling cases</article-title><source>Acta Paediatr Taiwan</source><year>2004</year><volume>45</volume><fpage>94</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">15335119</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name></person-group><article-title>The role of EBV in the development of Kawasaki disease</article-title><year>1997</year><conf-name>5th West-Pacific allergy symposium</conf-name><fpage>241</fpage><lpage>244</lpage></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocholl</surname><given-names>C</given-names></name><name><surname>Gerber</surname><given-names>K</given-names></name><name><surname>Daly</surname><given-names>J</given-names></name><name><surname>Pavia</surname><given-names>AT</given-names></name><name><surname>Byington</surname><given-names>CL</given-names></name></person-group><article-title>Adenoviral infections in children: the impact of rapid diagnosis</article-title><source>Pediatrics</source><year>2004</year><volume>113</volume><fpage>e51</fpage><lpage>e56</lpage><pub-id pub-id-type="pmid">14702495</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DS</given-names></name></person-group><article-title>Immunologic aspect in Kawasaki disease</article-title><source>J Korean Pediatr Cardiol Soc</source><year>2003</year><volume>7</volume><fpage>306</fpage><lpage>310</lpage></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowley</surname><given-names>AH</given-names></name><name><surname>Shulman</surname><given-names>ST</given-names></name></person-group><article-title>Kawasaki syndrome</article-title><source>Pediatrc Clin N Am</source><year>1999</year><volume>46</volume><fpage>313</fpage><lpage>329</lpage></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>SF</given-names></name><name><surname>Chang</surname><given-names>JS</given-names></name><name><surname>Peng</surname><given-names>CT</given-names></name><name><surname>Shi</surname><given-names>YR</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name></person-group><article-title>Polymorphism of angiotenisn-1 converting enzyme gene and Kawasaki disease</article-title><source>Pediatr Cardiol</source><year>2004</year><volume>25</volume><fpage>529</fpage><lpage>533</lpage><pub-id pub-id-type="pmid">15164145</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubert</surname><given-names>C</given-names></name><name><surname>Houot</surname><given-names>AM</given-names></name><name><surname>Corvol</surname><given-names>P</given-names></name><name><surname>Soubrier</surname><given-names>F</given-names></name></person-group><article-title>Structure of angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene</article-title><source>J Biol Chem</source><year>1991</year><volume>266</volume><fpage>15377</fpage><lpage>15383</lpage><pub-id pub-id-type="pmid">1651327</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manning</surname><given-names>MW</given-names></name><name><surname>Cassis</surname><given-names>LA</given-names></name><name><surname>Daugherty</surname><given-names>A</given-names></name></person-group><article-title>Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2003</year><volume>23</volume><fpage>483</fpage><lpage>488</lpage><pub-id pub-id-type="pmid">12615694</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamblin</surname><given-names>N</given-names></name><name><surname>Hermant</surname><given-names>X</given-names></name><name><surname>Lablanche</surname><given-names>JM</given-names></name><name><surname>Helbecque</surname><given-names>N</given-names></name><name><surname>Amouyel</surname><given-names>P</given-names></name><name><surname>Bauters</surname><given-names>C</given-names></name></person-group><article-title>Angiotensin converting enzyme and angiotensin II type I receptor polymorphisms in patients with coronary aneurysms</article-title><source>Thromb J</source><year>2003</year><volume>1</volume><fpage>5</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">12971828</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>A</given-names></name><name><surname>Narayanan</surname><given-names>S</given-names></name><name><surname>Waclawiw</surname><given-names>MA</given-names></name><name><surname>Epstein</surname><given-names>N</given-names></name><name><surname>Quyyumi</surname><given-names>AA</given-names></name></person-group><article-title>The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity</article-title><source>J Am Coll Cardiol</source><year>2000</year><volume>36</volume><fpage>1579</fpage><lpage>1586</lpage><pub-id pub-id-type="pmid">11079661</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheer</surname><given-names>WD</given-names></name><name><surname>Boudreau</surname><given-names>DA</given-names></name><name><surname>Hixson</surname><given-names>JE</given-names></name><name><surname>McGill</surname><given-names>HC</given-names></name><name><surname>Newman</surname><given-names>WP</given-names><suffix>3rd</suffix></name><name><surname>Tracy</surname><given-names>RE</given-names></name><name><surname>Zieske</surname><given-names>AW</given-names></name><name><surname>Stong</surname><given-names>JP</given-names></name></person-group><article-title>ACE insert/delete polymorphism and atherosclerosis</article-title><source>Atherosclerosis</source><year>2005</year><volume>178</volume><fpage>241</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">15694930</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigat</surname><given-names>B</given-names></name><name><surname>Hubert</surname><given-names>C</given-names></name><name><surname>Alhenc-Gelas</surname><given-names>F</given-names></name><name><surname>Cambien</surname><given-names>F</given-names></name><name><surname>Corvol</surname><given-names>P</given-names></name><name><surname>Soubrier</surname><given-names>F</given-names></name></person-group><article-title>An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels</article-title><source>J Clin Invest</source><year>1990</year><volume>86</volume><fpage>1343</fpage><lpage>1346</lpage><pub-id pub-id-type="pmid">1976655</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiret</surname><given-names>L</given-names></name><name><surname>Rigat</surname><given-names>B</given-names></name><name><surname>Visvikis</surname><given-names>S</given-names></name><name><surname>Breda</surname><given-names>C</given-names></name><name><surname>Corvol</surname><given-names>P</given-names></name><name><surname>Cambien</surname><given-names>F</given-names></name><name><surname>Soubrier</surname><given-names>F</given-names></name></person-group><article-title>Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I converting enzyme (ACE) gene controls plasma ACE levels</article-title><source>Am J Hum Genet</source><year>1992</year><volume>51</volume><fpage>197</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">1319114</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frossard</surname><given-names>PM</given-names></name><name><surname>Lestringant</surname><given-names>GG</given-names></name><name><surname>Obineche</surname><given-names>EN</given-names></name><name><surname>Hill</surname><given-names>SH</given-names></name></person-group><article-title>The angiotensin-converting enzyme (ACE) gene insertion/deletion dimorphism tracks with higher serum ACE activities in both younger and older subjects</article-title><source>Ann Saudi Med</source><year>1998</year><volume>18</volume><fpage>289</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">17344674</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danser</surname><given-names>AH</given-names></name><name><surname>Schunkert</surname><given-names>H</given-names></name></person-group><article-title>Renin-angiotensin system gene polymorphism: potential mechanisms for their association with cardiovascular diseases</article-title><source>Eur J Pharmacol</source><year>2000</year><volume>410</volume><fpage>303</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">11134678</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caldwell</surname><given-names>PR</given-names></name><name><surname>Segal</surname><given-names>BC</given-names></name><name><surname>Hsu</surname><given-names>KC</given-names></name><name><surname>Das</surname><given-names>M</given-names></name><name><surname>Softer</surname><given-names>RL</given-names></name></person-group><article-title>Angiotensin converting enzyme: vascular endothelial localization</article-title><source>Science</source><year>1976</year><volume>191</volume><fpage>1050</fpage><lpage>1051</lpage><pub-id pub-id-type="pmid">175444</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falcini</surname><given-names>F</given-names></name><name><surname>Generini</surname><given-names>S</given-names></name><name><surname>Pigone</surname><given-names>A</given-names></name><name><surname>Leoncini</surname><given-names>G</given-names></name><name><surname>Cimaz</surname><given-names>R</given-names></name><name><surname>Partsch</surname><given-names>G</given-names></name><name><surname>Matucci-Cerinic</surname><given-names>M</given-names></name></person-group><article-title>Are angiotensin converting enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease</article-title><source>Endothelium</source><year>1999</year><volume>6</volume><fpage>209</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">10365772</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukazawa</surname><given-names>R</given-names></name><name><surname>Sonobe</surname><given-names>T</given-names></name><name><surname>Hamamoto</surname><given-names>K</given-names></name><name><surname>Hamaoka</surname><given-names>K</given-names></name><name><surname>Sakata</surname><given-names>K</given-names></name><name><surname>Asano</surname><given-names>T</given-names></name><name><surname>Imai</surname><given-names>T</given-names></name><name><surname>Kamisago</surname><given-names>M</given-names></name><name><surname>Ohkubo</surname><given-names>T</given-names></name><name><surname>Uchikoba</surname><given-names>Y</given-names></name><name><surname>Ikegami</surname><given-names>E</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Ogawa</surname><given-names>S</given-names></name></person-group><article-title>Possible synergic effect of angiotensin-I converting enzyme gene insertion/deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease</article-title><source>Pediatr Res</source><year>2004</year><volume>56</volume><fpage>597</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">15295089</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slowik</surname><given-names>A</given-names></name><name><surname>Borratynsky</surname><given-names>A</given-names></name><name><surname>Pera</surname><given-names>J</given-names></name><name><surname>Betlej</surname><given-names>M</given-names></name><name><surname>Dziedzic</surname><given-names>T</given-names></name><name><surname>Krzyszkowski</surname><given-names>T</given-names></name><name><surname>Czepko</surname><given-names>R</given-names></name><name><surname>Figlewicz</surname><given-names>DA</given-names></name><name><surname>Szczudlik</surname><given-names>A</given-names></name></person-group><article-title>II genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm</article-title><source>Stroke</source><year>2004</year><volume>35</volume><fpage>1594</fpage><lpage>1597</lpage><pub-id pub-id-type="pmid">15166392</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Kataoka</surname><given-names>S</given-names></name><name><surname>Kakihara</surname><given-names>T</given-names></name><name><surname>Tanaki</surname><given-names>A</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Uchiyama</surname><given-names>M</given-names></name></person-group><article-title>High incidence of angiotensin 1 converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm</article-title><source>Eur J Pediatr</source><year>1997</year><volume>156</volume><fpage>266</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">9128808</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic characteristics of Kawasaki disease patients and control group</p></caption><graphic xlink:href="jkms-21-208-i001"/><table-wrap-foot><fn><p><italic>p</italic>&#x0003e;0.05. Co A., coronary artery.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Prevalence of angiotensin converting enzyme genotype in Kawasaki disease patients and control group</p></caption><graphic xlink:href="jkms-21-208-i002"/><table-wrap-foot><fn><p><sup>*</sup><italic>p</italic>&#x0003c;0.01; odds ratio=0.2; <sup>&#x02020;</sup><italic>p</italic>&#x0003c;0.01; odds ratio=3.3. ACE, angiotensin converting enzyme.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Deletion/insertion allelic prevalence of angiotensin converting enzyme gene in Kawasaki disease patients and control group</p></caption><graphic xlink:href="jkms-21-208-i003"/><table-wrap-foot><fn><p><sup>*</sup><italic>p</italic>&#x0003c;0.05. odds ratio=1.78.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Angiotensin converting enzyme genotype of Kawasaki patients with and without coronary dilatation</p></caption><graphic xlink:href="jkms-21-208-i004"/><table-wrap-foot><fn><p><sup>*</sup><italic>p</italic>&#x0003e;0.05. Co A., coronary artery; ACE, angiotensin converting enzyme.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Deletion/insertion allelic prevalence of angiotensin converting enzyme gene of Kawasaki patients with and without coronary dilatation</p></caption><graphic xlink:href="jkms-21-208-i005"/><table-wrap-foot><fn><p><sup>*</sup><italic>p</italic>&#x0003e;0.05. Co A., coronary artery.</p></fn></table-wrap-foot></table-wrap></floats-group></article>